
Strategy
Our strategy is to build a leading, focused medicines company powered by advanced therapy platforms and data science.

Novartis Pipeline
Our industry leading portfolio is focused on transforming the standard of care for patients worldwide.

Products
Learn more about treatments currently offered by Novartis and Advanced Accelerator Applications.
Our vision is to become the most valued and trusted medicines company in the world
Supporting units
Development
Development oversees the development of new medicines and manages Novartis clinical trials to bring innovative medicines to patients.
Biomedical Research
Biomedical Research collaborates across scientific and organizational boundaries, focusing on powerful new technologies to help produce therapeutic breakthroughs.
Operations
Operations includes Manufacturing and Supply, and Services and Technology Solutions, providing high-quality products, services and technology solutions.
Novartis companies
Advanced Accelerator Applications
Advanced Accelerator Applications is a Novartis company focused exclusively on radioligand therapy and precision imaging.
Chinook Therapeutics
Chinook is a clinical-stage biopharmaceutical company discovering, developing and commercializing precision medicines for rare, severe chronic kidney diseases.
Gyroscope Therapeutics
Gyroscope Therapeutics is a clinical-stage gene therapy company focused on diseases of the eye.
Novartis leadership
25 Years of Novartis
From dyes and chemicals to breakthrough innovation. Although only 25 years young, Novartis has a rich company history that roots back more than 250 years.